{
    "Title": "Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo",
    "URL": "https://doi.org/10.1371/journal.pntd.0007072",
    "Published": "January 30, 2019",
    "Subject_Areas": [
        "Viral replication",
        "Viral vaccines",
        "RNA polymerase",
        "Mouse models",
        "Antiviral therapy",
        "Flow cytometry",
        "Dengue virus",
        "Flaviviruses"
    ],
    "Authors": {
        "Caroline S. de Freitas": [
            "Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ, Brazil",
            "National Institute for Science and Technology on Innovation on Neglected Diseases (INCT/IDN), Center for Technological Development in Health (CDTS), Fiocruz, Rio de Janeiro, RJ, Brazil"
        ],
        "Luiza M. Higa": [
            "Laboratório de Virologia Molecular, Instituto de Biologia, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil"
        ],
        "Carolina Q. Sacramento": [
            "Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ, Brazil",
            "National Institute for Science and Technology on Innovation on Neglected Diseases (INCT/IDN), Center for Technological Development in Health (CDTS), Fiocruz, Rio de Janeiro, RJ, Brazil"
        ],
        "André C. Ferreira": [
            "Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ, Brazil",
            "National Institute for Science and Technology on Innovation on Neglected Diseases (INCT/IDN), Center for Technological Development in Health (CDTS), Fiocruz, Rio de Janeiro, RJ, Brazil"
        ],
        "Patrícia A. Reis": [
            "Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ, Brazil"
        ],
        "Rodrigo Delvecchio": [
            "Laboratório de Virologia Molecular, Instituto de Biologia, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil"
        ],
        "Fabio L. Monteiro": [
            "Laboratório de Virologia Molecular, Instituto de Biologia, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil"
        ],
        "Giselle Barbosa-Lima": [
            "Instituto Nacional de Infectologia (INI), Fiocruz, Rio de Janeiro, RJ, Brazil"
        ],
        "Harrison James Westgarth": [
            "Laboratório de Virologia Molecular, Instituto de Biologia, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil"
        ],
        "Yasmine Rangel Vieira": [
            "National Institute for Science and Technology on Innovation on Neglected Diseases (INCT/IDN), Center for Technological Development in Health (CDTS), Fiocruz, Rio de Janeiro, RJ, Brazil",
            "Instituto Nacional de Infectologia (INI), Fiocruz, Rio de Janeiro, RJ, Brazil"
        ],
        "Mayara Mattos": [
            "Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ, Brazil",
            "National Institute for Science and Technology on Innovation on Neglected Diseases (INCT/IDN), Center for Technological Development in Health (CDTS), Fiocruz, Rio de Janeiro, RJ, Brazil"
        ],
        "Natasha Rocha": [
            "Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ, Brazil",
            "National Institute for Science and Technology on Innovation on Neglected Diseases (INCT/IDN), Center for Technological Development in Health (CDTS), Fiocruz, Rio de Janeiro, RJ, Brazil"
        ],
        "Lucas Villas Bôas Hoelz": [
            "Instituto de Tecnologia de Fármacos (Farmanguinhos), Fiocruz, Rio de Janeiro, RJ, Brazil"
        ],
        "Rennan Papaleo Paes Leme": [
            "Instituto de Tecnologia de Fármacos (Farmanguinhos), Fiocruz, Rio de Janeiro, RJ, Brazil"
        ],
        "Mônica M. Bastos": [
            "Instituto de Tecnologia de Fármacos (Farmanguinhos), Fiocruz, Rio de Janeiro, RJ, Brazil"
        ],
        "Gisele Olinto L. Rodrigues": [
            "Center for Research and Development of Pharmaceuticals, Institute of Biological Sciences (ICB), Universidade Federal de Minas Gerais (UFMG), Minas Gerais, Brazil",
            "Research Group in Arboviral Diseases, Department of Morphology, Institute of Biological Sciences (ICB), Universidade Federal de Minas Gerais (UFMG), Minas Gerais, Brazil"
        ],
        "Carla Elizabeth M. Lopes": [
            "Center for Research and Development of Pharmaceuticals, Institute of Biological Sciences (ICB), Universidade Federal de Minas Gerais (UFMG), Minas Gerais, Brazil",
            "Research Group in Arboviral Diseases, Department of Morphology, Institute of Biological Sciences (ICB), Universidade Federal de Minas Gerais (UFMG), Minas Gerais, Brazil"
        ],
        "Celso Martins Queiroz-Junior": [
            "Cardiac Lab, Department of Morphology, Institute of Biological Sciences (ICB), Universidade Federal de Minas Gerais (UFMG), Minas Gerais, Brazil"
        ],
        "Cristiano X. Lima": [
            "Departamento de Cirurgia, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil"
        ],
        "Vivian V. Costa": [
            "Center for Research and Development of Pharmaceuticals, Institute of Biological Sciences (ICB), Universidade Federal de Minas Gerais (UFMG), Minas Gerais, Brazil",
            "Research Group in Arboviral Diseases, Department of Morphology, Institute of Biological Sciences (ICB), Universidade Federal de Minas Gerais (UFMG), Minas Gerais, Brazil"
        ],
        "Mauro M. Teixeira": [
            "Center for Research and Development of Pharmaceuticals, Institute of Biological Sciences (ICB), Universidade Federal de Minas Gerais (UFMG), Minas Gerais, Brazil",
            "Immunopharmacology Lab, Department of Biochemistry and Immunology, Institute of Biological Sciences (ICB), Universidade Federal de Minas Gerais (UFMG), Minas Gerais, Brazil"
        ],
        "Fernando A. Bozza": [
            "Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ, Brazil",
            "Instituto Nacional de Infectologia (INI), Fiocruz, Rio de Janeiro, RJ, Brazil"
        ],
        "Patrícia T. Bozza": [
            "Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ, Brazil"
        ],
        "Nubia Boechat": [
            "Instituto de Tecnologia de Fármacos (Farmanguinhos), Fiocruz, Rio de Janeiro, RJ, Brazil"
        ],
        "Amilcar Tanuri": [
            "Laboratório de Virologia Molecular, Instituto de Biologia, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil"
        ],
        "Thiago Moreno L. Souza": [
            "Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz (IOC), Fundação Oswaldo Cruz (Fiocruz), Rio de Janeiro, RJ, Brazil",
            "National Institute for Science and Technology on Innovation on Neglected Diseases (INCT/IDN), Center for Technological Development in Health (CDTS), Fiocruz, Rio de Janeiro, RJ, Brazil",
            "Instituto Nacional de Infectologia (INI), Fiocruz, Rio de Janeiro, RJ, Brazil"
        ]
    }
}